These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2158559)

  • 21. Synthesis and structure-activity studies of some disubstituted phenylisoxazoles against human picornavirus.
    Diana GD; Cutcliffe D; Oglesby RC; Otto MJ; Mallamo JP; Akullian V; McKinlay MA
    J Med Chem; 1989 Feb; 32(2):450-5. PubMed ID: 2913305
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of three structurally related antiviral compounds in complex with human rhinovirus 16.
    Hadfield AT; Diana GD; Rossmann MG
    Proc Natl Acad Sci U S A; 1999 Dec; 96(26):14730-5. PubMed ID: 10611281
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The site of attachment in human rhinovirus 14 for antiviral agents that inhibit uncoating.
    Smith TJ; Kremer MJ; Luo M; Vriend G; Arnold E; Kamer G; Rossmann MG; McKinlay MA; Diana GD; Otto MJ
    Science; 1986 Sep; 233(4770):1286-93. PubMed ID: 3018924
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel [(biphenyloxy)propyl]isoxazole derivatives for inhibition of human rhinovirus 2 and coxsackievirus B3 replication.
    Makarov VA; Riabova OB; Granik VG; Wutzler P; Schmidtke M
    J Antimicrob Chemother; 2005 Apr; 55(4):483-8. PubMed ID: 15743897
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure determination of antiviral compound SCH 38057 complexed with human rhinovirus 14.
    Zhang A; Nanni RG; Li T; Arnold GF; Oren DA; Jacobo-Molina A; Williams RL; Kamer G; Rubenstein DA; Li Y
    J Mol Biol; 1993 Apr; 230(3):857-67. PubMed ID: 8386772
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An evaluation of the antirhinoviral activity of acetylfuran replacements for 3-methylisoxazoles. Are 2-acetylfurans bioisosteres for 3-methylisoxazoles?
    Bailey TR; Diana GD; Mallamo JP; Vescio N; Draper TL; Carabateas PM; Long MA; Giranda VL; Dutko FJ; Pevear DC
    J Med Chem; 1994 Nov; 37(24):4177-84. PubMed ID: 7990117
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and evaluation of novel chloropyridazine derivatives as potent human rhinovirus (HRV) capsid-binding inhibitors.
    Fan SY; Zheng ZB; Mi CL; Zhou XB; Yan H; Gong ZH; Li S
    Bioorg Med Chem; 2009 Jan; 17(2):621-4. PubMed ID: 19091578
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stabilization of human rhinovirus serotype 2 against pH-induced conformational change by antiviral compounds.
    Gruenberger M; Pevear D; Diana GD; Kuechler E; Blaas D
    J Gen Virol; 1991 Feb; 72 ( Pt 2)():431-3. PubMed ID: 1847178
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Isoxazoles with antipicornavirus activity.
    Diana GD; McKinlay MA; Brisson CJ; Zalay ES; Miralles JV; Salvador UJ
    J Med Chem; 1985 Jun; 28(6):748-52. PubMed ID: 2989517
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An orally bioavailable oxime ether capsid binder with potent activity against human rhinovirus.
    Watson KG; Brown RN; Cameron R; Chalmers DK; Hamilton S; Jin B; Krippner GY; Luttick A; McConnell DB; Reece PA; Ryan J; Stanislawski PC; Tucker SP; Wu WY; Barnard DL; Sidwell RW
    J Med Chem; 2003 Jul; 46(15):3181-4. PubMed ID: 12852746
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dissociation of an antiviral compound from the internal pocket of human rhinovirus 14 capsid.
    Li Y; Zhou Z; Post CB
    Proc Natl Acad Sci U S A; 2005 May; 102(21):7529-34. PubMed ID: 15899980
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Novel Series of Highly Potent Small Molecule Inhibitors of Rhinovirus Replication.
    Kim J; Jung YK; Kim C; Shin JS; Scheers E; Lee JY; Han SB; Lee CK; Neyts J; Ha JD; Jung YS
    J Med Chem; 2017 Jul; 60(13):5472-5492. PubMed ID: 28581749
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic and molecular analyses of spontaneous mutants of human rhinovirus 14 that are resistant to an antiviral compound.
    Heinz BA; Rueckert RR; Shepard DA; Dutko FJ; McKinlay MA; Fancher M; Rossmann MG; Badger J; Smith TJ
    J Virol; 1989 Jun; 63(6):2476-85. PubMed ID: 2542566
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural analysis of a series of antiviral agents complexed with human rhinovirus 14.
    Badger J; Minor I; Kremer MJ; Oliveira MA; Smith TJ; Griffith JP; Guerin DM; Krishnaswamy S; Luo M; Rossmann MG
    Proc Natl Acad Sci U S A; 1988 May; 85(10):3304-8. PubMed ID: 2835768
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design and structure-activity relationships of novel inhibitors of human rhinovirus 3C protease.
    Kawatkar SP; Gagnon M; Hoesch V; Tiong-Yip C; Johnson K; Ek M; Nilsson E; Lister T; Olsson L; Patel J; Yu Q
    Bioorg Med Chem Lett; 2016 Jul; 26(14):3248-3252. PubMed ID: 27265257
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacophore-based design, synthesis, and biological evaluation of novel chloro-pyridazine piperazines as human rhinovirus (HRV-3) inhibitors.
    Wang H; Xiao J; Gao D; Zhang X; Yan H; Gong Z; Sun T; Li S
    Bioorg Med Chem Lett; 2011 Feb; 21(3):1057-9. PubMed ID: 21215622
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular dynamics simulations of human rhinovirus and an antiviral compound.
    Speelman B; Brooks BR; Post CB
    Biophys J; 2001 Jan; 80(1):121-9. PubMed ID: 11159387
    [TBL] [Abstract][Full Text] [Related]  

  • 38. VP1 sequencing of all human rhinovirus serotypes: insights into genus phylogeny and susceptibility to antiviral capsid-binding compounds.
    Ledford RM; Patel NR; Demenczuk TM; Watanyar A; Herbertz T; Collett MS; Pevear DC
    J Virol; 2004 Apr; 78(7):3663-74. PubMed ID: 15016887
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design, synthesis and biological evaluation of novel aminothiazoles as antiviral compounds acting against human rhinovirus.
    Décor A; Grand-Maître C; Hucke O; O'Meara J; Kuhn C; Constantineau-Forget L; Brochu C; Malenfant E; Bertrand-Laperle M; Bordeleau J; Ghiro E; Pesant M; Fazal G; Gorys V; Little M; Boucher C; Bordeleau S; Turcotte P; Guo T; Garneau M; Spickler C; Gauthier A
    Bioorg Med Chem Lett; 2013 Jul; 23(13):3841-7. PubMed ID: 23726345
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design, synthesis and in vitro evaluation of novel chroman-4-one, chroman, and 2H-chromene derivatives as human rhinovirus capsid-binding inhibitors.
    Conti C; Proietti Monaco L; Desideri N
    Bioorg Med Chem; 2011 Dec; 19(24):7357-64. PubMed ID: 22088306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.